IL6 and rheumatoid arthritis: Since TNF-α is known to mediate the IL-6 production by human monocytes in the arthritic joint, both, anti-IL-6 receptor and anti-TNF-α targeted antibodies proved to be very effective in the treatment of RA (45, 46).